Here is the synopsis of our sample research paper on Fluids & Congestive Heart Failure. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 4 page research paper that addresses the problem of fluid overload among patients with congestive heart failure. Bibliography lists 5 sources.
Page Count:
4 pages (~225 words per page)
File: D0_khflchf.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
therapies that were once considered "gold standards" are now considered to be "obsolete and in some cases dangerous" (Davis, 2002, p. 36). HF is due to a variety of causes,
and in general terms, refers to when the heart is incapable of pumping sufficient blood to support the metabolic needs of the body. The classic term "congestive heart failure" does
not necessarily apply to all HF patients, as pulmonary and systemic congestion is not always present (Davis, 2002). However, sodium, in general, contributes to fluid retention and acerbate HF
symptoms. Therefore, it is recommended that HF patients should restrict sodium to 2 grams per day, avoid processed foods and any food that has more than 400 mg of sodium
per serving (Davis, 2002). Furthermore, heart patients should restrict fluid intake that goes above 2 liters per day, unless the patient develops hyponathremia (Davis, 2002). Alcohol should be entirely
avoided. In patients who are suffering from congestive heart failure (CHF), the importance of fluid monitoring is so significant that an implantable device has been invented that is designed
to automatically monitor fluid status in the thoracic cavity (Congestive heart failure, 2005). In 2005, physicians at St. Mary Medical Center in Pennsylvania successfully underwent the implantation procedure. By being
able to monitor heat patients who are at-risk for fluid retention, healthcare providers anticipate that this device will enable them forestall the symptoms of CHF, which include "shortness
of breath, fatigue, weight gain, swelling of the legs and reduced exercise capacity" as fluids further impede the capacity of the heart to function (Congestive heart failure, 2005, p. 391).
In 2006, the company producing this monitoring device, National Quality Care, Inc. (NQCI), reported that data obtained from animal studies involving their wearable ultra-filtration device demonstrates the effectiveness of removing
...